Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316141 | 1.00 | CA1 (0.33) | CA1CA2CA4KMT2A | |
| SCHEMBL13858690 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL1849298 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL61394 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL7340365 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL25327994 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL11594630 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL542776 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL7992221 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A | |
| SCHEMBL9956415 | 0.97 | KMT2A (0.36) | CA1CA2CA4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1967 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166645-A1 | PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2024-05-23 | — | — | US | claimed |
| EP-4289843-A1 | PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2023-12-13 | — | — | EP | claimed |
| US-20210246264-A1 | METHOD OF MAKING MIXTURE OF POLYMERS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2021-08-12 | — | — | US | claimed |
| EP-3810676-A1 | METHOD OF MAKING MIXTURE OF POLYMERS | Solvay Specialty Polymers Italy S.p.A. (IT) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243404-A1 | METHOD OF MAKING MIXTURE OF POLYMERS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2019-12-26 | — | — | WO | claimed |
| EP-3013802-B1 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-08-14 | — | — | EP | claimed |
| US-9770022-B2 | N-cycloalkyl-N-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2017-09-26 | — | — | US | claimed |
| US-20160150777-A1 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2016-06-02 | — | — | US | claimed |
| EP-3013802-A1 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2016-05-04 | — | — | EP | claimed |
| WO-2014206953-A1 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2014-12-31 | — | — | WO | claimed |
| US-6100271-A | Therapeutic compounds containing xanthinyl | CELL THERAPEUTICS, INC. (US) | 2000-08-08 | — | — | US | claimed |
| US-6043250-A | Methods for using therapeutic compounds containing xanthinyl | CELL THERAPEUTICS, INC. (US) | 2000-03-28 | — | — | US | claimed |
| EP-0934302-A2 | AMINOPHENOL DERIVATES | BAYER AG (DE) | 1999-08-11 | — | — | EP | claimed |
| WO-1998016522-A2 | AMINOPHENOL DERIVATES WITH FUNGICIDAL PROPERTY | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | claimed |
| EP-0746557-A4 | INTRACELLULAR SIGNALLING MEDIATORS | CELL THERAPEUTICS INC (US) | 1997-05-02 | — | — | EP | claimed |
| EP-0746557-A1 | INTRACELLULAR SIGNALLING MEDIATORS | CELL THERAPEUTICS, INC. (US) | 1996-12-11 | — | — | EP | claimed |
| WO-1995022546-A1 | INTRACELLULAR SIGNALLING MEDIATORS | CELL THERAPEUTICS, INC. (US) | 1995-08-24 | — | — | WO | claimed |
| WO-1995020589-A1 | CELL SIGNALING INHIBITORS | CELL THERAPEUTICS, INC. (US) | 1995-08-03 | — | — | WO | claimed |
| EP-0549391-A1 | Ophthalmic lenses based on polyurethanes derived from polythiols | ESSILOR INTERNATIONAL, Compagnie Générale d'Optique (FR) | 1993-06-30 | — | — | EP | claimed |
| US-4472383-A | HYPOTENSIVE AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1984-09-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166645-A1 | PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | SOS1, WEE1, SOS2 | CA1 3433/4885CA2 3015/4885CA4 2936/4885 |
| US-20160150777-A1 | N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES | CBR3, CYCS, CBR1 | CA1 3757/4885CA2 1876/4885CA4 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.